Press Releases
Complete Genomics is making headlines. Read the most recent news about Complete Genomics and advances in complete human genome sequencing.
BGI-Shenzhen Completes Acquisition of Complete Genomics
Mar 18, 2013
BGI-Shenzhen (“BGI”), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has successfully completed the acquisition of Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), an innovative leader in accurate whole human genomic sequencing.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Approval From The State Administration Of Foreign Exchange Of The Prc For Bgi-Shenzhen'S Proposed Acquisition Of Complete Genomics, Inc.
Mar 12, 2013
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the State Administration of Foreign Exchange of the People’s Republic of China regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Approval From The Ministry Of Commerce Of The Prc For Bgi-Shenzhen'S Proposed Acquisition Of Complete Genomics, Inc.
Feb 25, 2013
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained approval from the Ministry of Commerce of the People’s Republic of China regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Clearance From The National Development And Reform Commission Of The Prc For Bgi-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.
Jan 11, 2013
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the National Development and Reform Commission of the People’s Republic of China regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBgi-Shenzhen And Complete Genomics, Inc. Receive Early Termination Of Hart-Scott-Rodino Waiting Period
Jan 7, 2013
BGI-Shenzhen (“BGI”) and Complete Genomics, Inc. (Nasdaq: GNOM) (“Complete”) announced today that they have received early termination of the Hart-Scott-Rodino waiting period from the Federal Trade Commission (“FTC”) regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreBGI-Shenzhen and Complete Genomics, Inc. Receive CFIUS Clearance for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
Dec 28, 2012
BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (Nasdaq: GNOM) ("Complete") announced today that they have obtained clearance from the Committee on Foreign Investment in the United States ("CFIUS") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.
>> read moreComplete Genomics Reports Third Quarter 2012 Results
Nov 9, 2012
Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced financial results for its fiscal quarter ended September 30, 2012.
>> read moreComplete Genomics Announces Court's Favorable Ruling in Patent Litigation Against Illumina, Inc.
Oct 18, 2012
Complete Genomics, Inc. (Nasdaq:GNOM) today announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued an Order granting Complete's Motion for Partial Summary Judgment of invalidity in the patent infringement lawsuit filed against Complete by Illumina, Inc.
>> read moreComplete Genomics and BGI-Shenzhen Announce Definitive Agreement to Merge
Sep 17, 2012
MOUNTAIN VIEW, Calif. and SHENZHEN, China, Sept. 17, 2012 -- Complete Genomics, Inc. (Nasdaq:GNOM) ("Complete"), an innovative leader in whole human genomic sequencing, and BGI-Shenzhen ("BGI"), a leading international genomics company based in Shenzhen, China, today announced that they have entered into a definitive merger agreement. Through...
>> read moreComplete Genomics Reports Second Quarter 2012 Results
Aug 8, 2012
Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced financial results for its fiscal quarter ended June 30, 2012.
>> read moreWhole Genome Sequencing Study Provides Key Insight Into Human Evolution and Origin of Short Stature
Jul 24, 2012
Complete Genomics, Inc. (Nasdaq: GNOM) today announced that its high-accuracy, whole-genome sequencing service has been used to study human evolution in three African populations. The findings, to be published online today, will be highlighted on the cover of the Aug. 3 issue of the journal Cell.
>> read moreComplete Genomics to Bundle Ingenuity Analysis and Interpretation Software With Whole Genome Sequencing
Jul 24, 2012
Complete Genomics, Inc. (Nasdaq: GNOM) and Ingenuity® Systems Inc. today announced that Complete Genomics will bundle the Ingenuity Variant Analysis application with its research whole genome sequencing services.
>> read moreComplete Genomics Announces New Technology Developed to Set Standard for Clinical-Grade Genomes
Jul 11, 2012
Complete Genomics, Inc. (Nasdaq: GNOM), announced today that its Long Fragment Read (LFR) technology for whole genome sequencing dramatically improves accuracy, enables fully-phased genomes, and significantly reduces the amount of DNA required for testing.
>> read moreComplete Genomics, Inc. To Vigorously Defend Against Patent Infringement Suit
Jun 19, 2012
Complete Genomics, Inc. (Nasdaq: GNOM), announced today that it intends to vigorously defend itself against the patent infringement suit recently filed by Illumina, Inc. in the U.S. District Court for the Southern District of California.
>> read moreComplete Genomics Announces Restructuring Plan and Review of Strategic Alternatives
Jun 5, 2012
Complete Genomics, Inc. (Nasdaq: GNOM), today announced that it is taking steps to reduce cash consumption and has engaged Jefferies & Company, Inc. to assist it in exploring strategic alternatives. The company also plans to focus on development of clinical applications for its whole human genome sequencing service, while continuing to provide high-quality genomes to research customers.
>> read moreWhole Genome Sequencing in Type 2 Diabetes Genetic Study
May 9, 2012
Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date
>> read moreComplete Genomics Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea
May 8, 2012
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today announced that it has signed four new distributor agreements with well-established Asia-Pacific life sciences companies
>> read moreComplete Genomics Reports First Quarter 2012 Results
May 7, 2012
Complete Genomics, Inc. (Nasdaq: GNOM) today announced financial results for its quarter ended March 31, 2012.
>> read more
Complete Genomics Schedules First Quarter 2012 Earnings Release and Announces Conference Call
May 3, 2012
Complete Genomics, Inc. (Nasdaq: GNOM) will release its first quarter 2012 financial results at approximately 1:00 p.m. PDT on May 7, 2012.
>> read moreComplete Genomics Now Accepts DNA Obtained From Saliva for Whole Human Genome Sequencing
Mar 29, 2012
Complete Genomics Inc. (NASDAQ: GNOM) has begun accepting DNA samples derived from human saliva.
>> read moreComplete Genomics Reports Fourth Quarter and Fiscal Year 2011 Results
Mar 8, 2012
Complete Genomics, Inc. (Nasdaq: GNOM), the whole human genome sequencing company, today announced financial results for the fourth quarter and fiscal year ended December 31, 2011.
>> read moreComplete Genomics Schedules Fourth Quarter and Fiscal Year 2011 Earnings Release and Announces Conference Call
Mar 5, 2012
Complete Genomics, Inc. (Nasdaq:GNOM) will release its fourth quarter and fiscal year 2011 financial results after markets close on March 8, 2012.
>> read moreComplete Genomics to Present at Two Upcoming Investor Conferences
Mar 2, 2012
Complete Genomics (NASDAQ: GNOM) today announced that members of its management team will present at the following conferences in March
>> read moreComplete Genomics Announces Formation of Genomic Medicine Advisory Board
Feb 29, 2012
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today announced the formation of its Genomic Medicine Advisory Board (GMAB).
>> read moreStudy Published in Journal Nature Suggests New Genomic Pathways for Neuroblastoma
Feb 24, 2012
Complete Genomics, Inc. (NASDAQ: GNOM) announced today that the journal Nature has published a neuroblastoma study conducted using the company’s high-depth whole human genome sequencing service.
>> read moreComplete Genomics Co-Authors Paper Demonstrating Impact of Hepatitis B Virus on Liver Cancer Genomes
Feb 23, 2012
Complete Genomics Inc. (NASDAQ: GNOM) announced today that Genome Research has published a paper it co-authored describing the effects of hepatitis B virus (HBV) integration into the genomes of liver cancer patients.
>> read moreComplete Genomics Named to MIT’s Technology Review Top 50 Innovative Companies List for Third-Consecutive Year
Feb 21, 2012
Complete Genomics Inc. (NASDAQ: GNOM) today announced that the company will be included in MIT’s Technology Review TR50, an annual list of the 50 most innovative technology companies in the world. It is the third-consecutive year that Complete Genomics has been named to the list.
>> read moreComplete Genomics Launches Genomic Discovery Software Partners Program
Feb 16, 2012
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today introduced its Genomic Discovery Software Partners Program.
>> read moreMayo Clinic Selects Complete Genomics to Provide Outsourced Whole Genome Sequencing
Feb 13, 2012
Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has been selected by Mayo Clinic’s Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics’ sequencing service for some of its large-scale whole genome sequencing projects.
>> read moreComplete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing
Jan 19, 2012
Complete Genomics Inc. (NASDAQ: GNOM) announced today that the Journal of Computational Biology has published online the company’s paper describing some of the computational methods that enable it to produce highly-accurate whole human genome sequencing data.
>> read moreComplete Genomics Announces Shipment of Approximately 3,000 Genomes in 2011
Jan 9, 2012
Complete Genomics, Inc. (Nasdaq: GNOM), today announced that the company delivered approximately 3,000 genomes to its customers in 2011 and is entering 2012 with contracts for approximately 5,800 genomes.
>> read moreComplete Genomics to Present at Oppenheimer Healthcare Conference
Dec 9, 2011
Complete Genomics (NASDAQ: GNOM) today announced that Ajay Bansal, Chief Financial Officer of Complete Genomics will present at the Oppenheimer 22nd Annual Healthcare Conference at 11:25 a.m. ET on Wednesday, December 14, 2011.
>> read moreComplete Genomics Reports Results for Third Quarter 2011
Nov 8, 2011
Complete Genomics, Inc. (Nasdaq: GNOM), the whole human genome sequencing company, today announced its financial results for the quarter ended September 30, 2011.
>> read moreComplete Genomics Schedules Third Quarter 2011 Earnings Release and Announces Conference Call
Nov 3, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) will release its third quarter 2011 financial results after markets close on November 7, 2011.
>> read moreComplete Genomics to Present at Upcoming Investor Conferences
Nov 3, 2011
Complete Genomics (NASDAQ: GNOM) today announced that Dr. Cliff Reid, chairman, president, and CEO of Complete Genomics will present at the following conferences in November
>> read moreComplete Genomics Launches Comprehensive Cancer Sequencing Service at ICHG/ASHG 2011
Nov 3, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, introduced its new Cancer Sequencing Service today at the International Congress of Human Genetics (ICHG) and American Society of Human Genetics (ASHG) Annual Meeting in Montréal.
>> read moreScripps Health and Complete Genomics Announce Collaboration Aimed at Unlocking Genetic Secrets of Healthy Aging
Oct 3, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, and the not-for-profit Scripps Health system today announced a major collaboration that will help further the Wellderly Study, a landmark scientific research initiative aimed at unlocking the genetic secrets of lifelong health.
>> read moreComplete Genomics Partners With Inova Health System to Sequence the Genomes of 500 Babies and Their Parents
Sep 8, 2011
MOUNTAIN VIEW, Calif., and FALLS CHURCH, Va. – Complete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company, and Inova Health System, a not-for-profit healthcare system based in Northern Virginia, today announced additional details about their partnership.
>> read moreComplete Genomics to Present at Three Upcoming Investor Conferences
Sep 1, 2011
Complete Genomics (NASDAQ: GNOM) today announced that members of its management team will present at the following conferences in September
>> read moreComplete Genomics Appoints Chief Commercial Officer and Chief Medical Officer
Aug 25, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the complete human genome sequencing company, today announced it has appointed Keith Raffel as chief commercial officer (CCO) and Dr. Jill Hagenkord as chief medical officer (CMO).
>> read moreComplete Genomics to Sequence More Than 1,000 Additional Genomes for National Cancer Institute’s Pediatric Cancer Study
Aug 24, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the complete human genome sequencing company, today announced additional details about the option that SAIC-Frederick Inc. has exercised to have Complete Genomics sequence the DNA from more than 500 pediatric cancer cases.
>> read more